RSS

CRISPR

A collaboration has been announced between gene editing and gene modulation tech company, Horizon Discovery, and a global pharma partner for the co-development and application of a novel CRISPR-based screening technology platform. Read more

Technology

Synthetic biology company, Oxford Genetics, has secured a major supply and licensing contract, worth millions, with a global ecommerce provider of reagents and tools to the research and clinical community. Read more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more

News

The Netherlands Cancer Institute (NKI) has granted exclusive worldwide licensing rights for its web tool, TIDE — Tracking of Indels by DEcomposition — to biotech company, Desktop Genetics (DTG). Read more

Technology

Horizon Discovery Group has extended its pre-existing non-exclusive, worldwide licence agreement with ERS Genomics to expand its coverage for the use of CRISPR gene editing technology. Read more

News